Home / Health / Weight Loss Drug Eases Asthma Woes
Weight Loss Drug Eases Asthma Woes
8 Sep
Summary
- Semaglutide users saw nearly 40% fewer asthma attacks.
- Higher doses of semaglutide showed stronger effects.
- Individuals with more pronounced asthma benefited most.
Patients managing asthma who are using semaglutide, a medication for diabetes and weight loss, may experience fewer respiratory attacks, according to recent research. The study observed a connection to reduced flare-ups of asthma and chronic obstructive pulmonary disease (COPD), with effects being more significant at higher doses of semaglutide.
Presented at the European Respiratory Society Congress in Barcelona, Spain, the study examined UK medical records of tens of thousands of individuals initiating GLP-1 receptor agonists. Researchers found that semaglutide use was associated with nearly a 40% decrease in asthma attacks and a 20% reduction in COPD flare-ups.
Experts emphasize that while these findings are encouraging, they should not alter current treatment decisions for lung conditions. Individuals with asthma or COPD should not commence GLP-1 receptor agonists solely for their respiratory issues outside of established prescribing guidelines. Further clinical trials are necessary to confirm these observations.
